Direkt zum Inhalt
Merck

Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a).

Bioorganic & medicinal chemistry letters (2010-04-07)
P Douglas Boatman, Thomas O Schrader, Michelle Kasem, Benjamin R Johnson, Philip J Skinner, Jae-Kyu Jung, Jerry Xu, Martin C Cherrier, Peter J Webb, Graeme Semple, Carleton R Sage, Jens Knudsen, Ruoping Chen, Andrew K Taggart, Ester Carballo-Jane, Jeremy G Richman
ZUSAMMENFASSUNG

Tricyclic pyrazole tetrazoles which are potent partial agonists of the high affinity niacin receptor, GPR109a, have been discovered and optimized. One of these compounds has proven to be effective at lowering free fatty acids in vitro and in vivo.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Nicotinsäure, ≥99.5% (HPLC)
Sigma-Aldrich
Nicotinsäure, ≥98%
Supelco
Nicotinsäure, analytical standard
Sigma-Aldrich
Nicotinsäure, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, ≥98%
Sigma-Aldrich
Nicotinsäure, meets USP testing specifications